VORRICHTUNGSBEHÄLTER

European patent · EP2872418 · In force

Register entry

Publication number
EP2872418
Application number
EP13812479
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 3, 2013
Published
May 20, 2015
Granted
Apr 8, 2020
Protection ends at the latest
Jul 2, 2033
Next annual fee due
Jul 31, 2027
IPC classes
B65D 83/00 (2006.01)
B65D 83/02 (2006.01)
A61M 5/00 (2006.01)
B65D 43/16 (2006.01)
Priority
US 201261667550 P 03.07.2012
PCT application
PCT/US2013/049322 03.07.2013
PCT publication
WO2014/008397 09.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Apr 8, 2020

    Granted

    Published in Swissreg on 08.04.2020

Parties

Holder

Bioverativ Therapeutics Inc.

225 Second Avenue, Waltham, MA 02451, US

Inventor

JANSON, Christine, P.

Dedham, MA 02026, US

PRESHER, Chad

Manchester, NH 03103, US

GANDHI, Nikhil

Holliston, MA 01746, US

JACOBY, Ethan, B.

Wellesley Hills, MA 02481, US

STEINMANN, Frederick, Carel

Milford, MA 01757, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.